# Cardinal Health Inc: Form 10-Q for the period ended Sep 30, 2024

- Company: [Cardinal Health Inc](/companies/cah.md) (CIK 721371)
- Form: 10-Q
- Filed: 2024-11-01
- Accepted by EDGAR: Nov 1, 2024, 08:58 ET
- Period: 2024-09-30
- Accession: 0000721371-24-000121
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/721371/000072137124000121/cah-20240930.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/721371/000072137124000121/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2024-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2024-07-01 to 2024-09-30 | $52.28bn | us-gaap:Revenues |
| Cost of revenue | 3 months, 2024-07-01 to 2024-09-30 | $50.38bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2024-07-01 to 2024-09-30 | $1.90bn | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2024-07-01 to 2024-09-30 | $1.28bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2024-07-01 to 2024-09-30 | $568.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2024-07-01 to 2024-09-30 | $32.0m | us-gaap:InterestExpense |
| Income tax | 3 months, 2024-07-01 to 2024-09-30 | $124.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2024-07-01 to 2024-09-30 | $416.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2024-07-01 to 2024-09-30 | $1.70 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2024-07-01 to 2024-09-30 | $1.71 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2024-07-01 to 2024-09-30 | 245,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2024-07-01 to 2024-09-30 | −$1.65bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2024-07-01 to 2024-09-30 | $90.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months, 2024-07-01 to 2024-09-30 | $128.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months, 2024-07-01 to 2024-09-30 | $375.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2024-09-30 | $2.87bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2024-09-30 | $32.91bn | us-gaap:AssetsCurrent |
| Total assets | at 2024-09-30 | $43.06bn | us-gaap:Assets |
| Current liabilities | at 2024-09-30 | $34.68bn | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | at 2024-09-30 | −$3.28bn | us-gaap:StockholdersEquity |

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/721371/000072137124000121/cah-20240930.htm

Filed Nov 1, 2024.
Source: SEC EDGAR, the filing index for accession 0000721371-24-000121. Last ingested by Listed: Nov 5, 2026, 12:30 ET. No prices; not investment advice.